Sequence Design
Therapeutic ASOs are designed in silico to target mRNA sequences of interest with optimal binding while minimizing off-target effects. Streamline sequence design and predict the best candidates for development and bioprocessing with Genedata Selector software. Insourced sequence synthesis information can be uploaded to IDBS Polar Biopharma Lifecycle Management software for easy data management and tracking across sites. Outsourcing oligonucleotide synthesis to IDT provides increased quality and scale aligned to development or manufacturing needs.